A human epithelial-like cell line derived from peritoneal implants from a patient with gonadotrophin-releasing
hormone (
GnRH) agonist-resistant
endometriosis graded as stage IVd according to the American Fertility Society classification was established in vitro. This cell line, designated FbEM-1, exhibited an epithelial-like morphology, grew in
suspension and was immunoreactive for cytokeratins 8, 18, 19,
vimentin and human leukocyte
class I antigens. The cultured cells were negative for various haematopoietic cell markers, including the lymphoid cell
antigens CD3, CD20 and CD45, von Willebrandt factor,
carcinoembryonic antigen and the
carcinoma antigen-125 (CA-125). In addition, the FbEM-1 cells were found to be moderately positive for
periodic acid Schiff's (PAS)
solution but were negative for
alpha-naphthyl acetate esterase,
peroxidase and
chloroacetate esterase activities. Using specific
antibodies against the
progesterone,
androgen and oestrogen receptors, approximately 40% and 5-10% of the cells immunostained for
progesterone and
androgen receptors respectively, while oestrogen receptors were not detected. On cytogenetic analysis using R-banding, these cells showed numerous
chromosomal aberrations, including loss of one chromosome X, 4q+, 5q+,
trisomy 7,8 and 10 and
tetrasomy of chromosomes 17, 18, 19 and 20. These data show that the continuously growing FbEM-1 cell line established from endometriotic implants may be useful in achieving better understanding of the histogenesis of
endometriosis.